Skip to main content
. Author manuscript; available in PMC: 2012 Dec 5.
Published in final edited form as: Eur J Pharmacol. 2011 Sep 19;671(1-3):18–25. doi: 10.1016/j.ejphar.2011.09.033

Fig. 1. Dehydroleucodine inhibited adipogenesis of 3T3-L1 preadipocytes without reducing cell viability.

Fig. 1

(A) 3T3-L1 preadipocytes were differentiated into adipocytes in the absence or in the presence of various amounts of DhL (0.65 to 10 μM) as described in Material and Methods. Results were represented as relative lipid contents. Data represent the mean ± S.E.M. of three independent experiments. *P < 0.05 by Student's t-test compared to DMSO and only induction media-treated cells. (B) Cells were treated with 8 μM DhL for either 24hrs (Day 1) or for 9 days (Day 9). Cell viability was measured using the MTT assay as described in Material and Methods. Data represent the mean ± S.E.M. of three independent experiments.